Evidence map›Paper›PMID 39595902›Full record

ReviewBrain sciences2024

Efficacy and Safety of Lithium for Suicide and Suicide-Related Behaviors in Youth: A Review of the Literature.

Gianluca Sesso, Francesca Bargnesi, Francesca Olzi, Giulia Mutti, Stefano Berloffa, Valentina Viglione, Pamela Fantozzi, Greta Tolomei, Fulvio Guccione, Annarita Milone and 1 more

Abstract readReview
In one paragraph

Review in Brain sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gianluca SessoIMT School for Advanced Studies, 55100 Lucca, Italy.ORCID 0000-0003-0435-2962
Francesca BargnesiDepartment of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Francesca OlziDepartment of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Giulia MuttiDepartment of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Stefano BerloffaDevelopmental Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.
Valentina ViglioneDevelopmental Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.ORCID 0000-0003-4164-3101
Pamela FantozziDevelopmental Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.ORCID 0000-0001-5492-8929
Greta TolomeiDevelopmental Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.ORCID 0009-0009-0854-2297
Fulvio GuccioneDevelopmental Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.
Annarita MiloneDevelopmental Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.ORCID 0000-0003-3170-1187
Gabriele MasiDevelopmental Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.ORCID 0000-0001-7770-926X

Funding

Ministero della Salute Ricerca Corrente 2024 and the "5 × 1000" voluntary contributions
6 · The paper itself

Abstract

objectivesThis systematic review evaluates the anti-suicidal properties of Lithium in children and adolescents with Bipolar Disorder (BD), addressing gaps in evidence regarding its efficacy and safety in reducing suicidality and self-harming behaviors.

methodsA comprehensive literature search was conducted across PubMed, Web of Science, and Scopus up to February 2024. Eligible studies were those focusing on patients aged 25 years or younger, examining Lithium therapy and its impact on suicidal ideation and behaviors. The review included randomized controlled trials, longitudinal prospective and retrospective studies, and cross-sectional studies, while excluding expert opinions and case reports.

resultsEvidence generally supports the efficacy of Lithium in reducing suicidal ideation and self-harming behaviors in youth with BD, though results are mixed. Randomized controlled trials demonstrated its effectiveness in mitigating suicidal thoughts during acute manic episodes, with effects persisting post-treatment. Longitudinal studies suggested that Lithium might offer superior outcomes compared to other mood stabilizers, although its specific impact on suicidality remains inconclusive. Cross-sectional studies and retrospective analyses reveal associations between Lithium use and reduced self-harming behaviors, but causality remains uncertain. While mood-stabilizing effects of Lithium offer potential benefits for reducing suicidality in youth, evidence on its direct impact on emotional dysregulation (ED) and long-term efficacy is limited. Variability in individual responses and adherence issues underscore the need for further research. Future studies should include larger, diverse samples, focus on ED symptoms, and explore Lithium mechanisms in suicidality prevention.

conclusionsLithium remains a promising treatment for mood stabilization and reduction in suicidality in youth with BD.

Indexed as

adolescentslithiumsuicideyouth

Identifiers

PMID39595902
PMCPMC11592384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.